Clinical Study
Intravitreal Melphalan for Vitreous Seeds: Initial Experience in China
Figure 1
Control of resistant seeds in case 3 (upper) and case 13 (lower). (a) and (c) Vitreous seeds (arrow) and tumor (arrow head) were still active after 4 cycles of IVC and focal consolidation in case 3 and 4 cycles of IVC and 2 cycles of OAC in case 13. (b) After 11 cycles of intravitreal melphalan, 2 additional IVC, and focal consolidation, vitreous seeds regressed into type 1 and tumor (arrow head) shrank and completely calcified. (d) After 4 cycles of intravitreal melphalan, one additional OAC, and focal consolidation, vitreous seeds regressed into type 0 and tumor (arrow head) shrank and completely calcified.
(a) |
(b) |
(c) |
(d) |